undefined undefined
NaN.000
NaN.00%
Cantor Fitzgerald analyst Ross Osborn reiterates VolitionRX (AMEX:VNRX) with a Overweight and maintains $2.5 price target.
05-16 23:11
In a report released yesterday, Ross Osborn from Cantor Fitzgerald reiterated a...
05-16 20:05
VolitionRx shares are trading lower after the company reported worse-than-expec...
05-15 02:04
Conference call to take place on Tuesday May 14 at 8:30 a.m. U.S Eastern Time H...
05-08 20:00
VolitionRX (VNRX) has shared an announcement. VolitionRx Limited is set for sig...
04-27 04:23
HENDERSON, Nev., April 23, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has announced that its Nu.Q® Vet Cancer Test is n...
04-23 20:00
Benchmark Co. analyst Bruce Jackson maintained a Hold rating on VolitionRX (VNR...
03-27 20:26
Companies Reporting Before The Bell • Bitcoin Depot (NASDAQ:BTM) is expected to report quarterly loss at $0.08 per share on revenue of $161.50 million.
03-25 17:33
Major earnings expected after the bell on Monday include: Westport Fuel Systems (WPRT) Bakkt Holdings (BKKT) TMC the metals company (TMC) Dada Nexus Limited (DADA) Other earnings slated for release af...
03-25 05:35
VolitionRX (AMEX:VNRX) is set to give its latest quarterly earnings report on M...
03-22 22:02